Groupon, Inc. (NASDAQ:GRPN) ended the last trading day at $3.84. Company weekly volatility is calculated as 13.67% and price to cash ratio as 2.36. Groupon, Inc. (NASDAQ:GRPN) showed a weekly performance of 70.67%.
On 12 February, Groupon, Inc. (NASDAQ:GRPN) said that, its 4Q15 results indicate stability, particularly in North America. The region’s local gross billings and gross profits grew 6 percent year on year and 8 percent year on year, respectively, while gross profits in the EMEA declined 14 percent year on year due to lower than expected billings.
On 18 February, CTI BioPharma Corp. (NASDAQ:CTIC) shares advanced 21.50% and was closed at $0.61. CTIC EPS growth in last 5 year was 38.90%. CTI BioPharma Corp. (NASDAQ:CTIC) year to date (YTD) performance is -50.70%.
On 10 February, CTI BioPharma Corp. (NASDAQ:CTIC) provided an update regarding the clinical studies being conducted under the Company’s Investigational New Drug (“IND”) application for pacritinib.
General Electric Company (NYSE:GE) shares decreased -0.89% in last trading session and ended the day at $29.08. GE Gross Margin is 26.60% and its has a return on assets of -6.00%. General Electric Company (NYSE:GE) quarterly performance is -3.50%.
General Electric Company (NYSE:GE) declared a $0.23 per share dividend on the outstanding common stock of the Company payable April 25, 2016 to shareowners of record at the close of business on February 29, 2016. The ex-dividend date is February 25, 2016.
Johnson & Johnson (NYSE:JNJ) caters to the Healthcare space. It has a net profit margin of 22.00% and weekly performance is 2.47%. On the last day of trading company shares ended up at $104.24. Johnson & Johnson (NYSE:JNJ) distance from 50-day simple moving average (SMA50) is 2.84%.
On 10 February, Johnson & Johnson (NYSE:JNJ) said that, its oncology business rose 14.8% at constant exchange rates to $1.3 billion during 4Q15, due to increased sales of Zytiga and Imbruvica and the successful launch of Darzalex. For 2015, the business’s revenues rose by 17.7% to $4.7 billion at constant exchange rates.
EndoChoice Holdings, Inc. (NYSE:GI) caters to the Healthcare space. It has a net profit margin of -85.20% and weekly performance is -0.69%. On the last day of trading company shares ended up at $4.29. EndoChoice Holdings, Inc. (NYSE:GI) distance from 50-day simple moving average (SMA50) is -38.16%.
EndoChoice Holdings, Inc. (NYSE:GI) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report issued on Friday, MarketBeat reports.
Leave a Reply